Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
复制标题
DNMT3A突变的急性髓系白血病免疫逃逸机制研究
DOI:
10.3389/fimmu.2021.653030
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Li D
中科院分区:
文献类型:
--
作者:
Que Y;Li H;Lin L;Zhu X;Xiao M;Wang Y;Zhu L;Li D
DNA (cytosine-5)-methyltransferase 3A (DNMT3A)-mutated acute myeloid leukemia (AML) has a poor prognosis, but the exact mechanism is still unclear. Here, we aimed to explore the mechanism of immune escape in AML with DNMT3A mutation. We constructed a DNMT3A knockout clone and DNMT3A-R882H-mutated clones. RNA-seq results showed that transcription factors and macrophage inflammatory proteins were significantly downregulated in the DNMT3A mutant clones. KEGG enrichment and gene set enrichment analysis (GSEA) showed that a large number of genes were enriched in inflammatory immune-related pathways, such as the toll-like receptor signaling pathway. Therefore, we co-cultured AML cells with macrophages. The DNMT3A-mutated AML cells attenuated M1 macrophage polarization and resisted its killing effect in vitro and in vivo. In xenografts, the tumor volumes in the experimental group were significantly larger than those in the control group, and the proportion of M2 macrophages was significantly higher. After the co-culture, the increase in pro-inflammatory cytokine expression in the mutant cells was significantly lower than that in the control group, while that in immunosuppressive factors was not significantly different. In co-cultivated supernatants, the concentration of inflammatory factors in the experimental group was significantly lower than that in the control group, while that of immunosuppressive factors was significantly higher. Resistin significantly promoted the expression of inflammatory proteins in AML cells. It relieved the inhibitory effect of DNMT3A mutation, promoted the phenotypic recovery of the co-cultured macrophages, eliminated resistance, and regulated the immune microenvironment. Thus, resistin may serve as an ancillary drug for patients with DNMT3A-mutated AML.
登录
查看更多内容
影响因子:
50.3
作者:
Russler-Germain DA;Spencer DH;Young MA;Lamprecht TL;Miller CA;Fulton R;Meyer MR;Erdmann-Gilmore P;Townsend RR;Wilson RK;Ley TJ
通讯作者:
Ley TJ
影响因子:
2.8
作者:
Schroder, Kate;Sweet, Matthew J.;Hume, David A.
通讯作者:
Hume, David A.
影响因子:
--
作者:
Ahmad, Rasheed;Shihab, Puthiyaveetil Kochumon;Behbehani, Kazem
通讯作者:
Behbehani, Kazem
DOI:
10.1056/nejmoa1005143
发表时间:
2010-12-16
期刊:
The New England journal of medicine
影响因子:
--
作者:
Ley TJ;Ding L;Walter MJ;McLellan MD;Lamprecht T;Larson DE;Kandoth C;Payton JE;Baty J;Welch J;Harris CC;Lichti CF;Townsend RR;Fulton RS;Dooling DJ;Koboldt DC;Schmidt H;Zhang Q;Osborne JR;Lin L;O'Laughlin M;McMichael JF;Delehaunty KD;McGrath SD;Fulton LA;Magrini VJ;Vickery TL;Hundal J;Cook LL;Conyers JJ;Swift GW;Reed JP;Alldredge PA;Wylie T;Walker J;Kalicki J;Watson MA;Heath S;Shannon WD;Varghese N;Nagarajan R;Westervelt P;Tomasson MH;Link DC;Graubert TA;DiPersio JF;Mardis ER;Wilson RK
通讯作者:
Wilson RK
影响因子:
20.3
作者:
Shaknovich, Rita;Cerchietti, Leandro;Melnick, Ari
通讯作者:
Melnick, Ari